The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions.
Coming after four years of clinical trials, the vaccine will only be available for older adults and people over the age of 12 who have at least one medical condition that means they’re at high risk from COVID, according to The New York Times.
Advisers at the Centers for Disease Control and Prevention have been debating whether to recommend COVID vaccines for only the most vulnerable. The decision to restrict who can access the Novavax vaccine would appear to resolve the question, at least in part.
The post RFK Jr.’s FDA Severely Restricts COVID Vaccine Use appeared first on The Daily Beast